Emmaus Life Sciences announces cooperation with UpScript to provide telemedicine solutions for patients with sickle cell disease

2021-11-16 07:50:02 By : Mr. Carler Chen

Is the recycling of fossil fuels real, or is it a stepping stone to a fossil-free future? Register now for our 11/17 webinar at 2pm Eastern Time

Partnership will expand patient access to Endari®

Torrance, California, November 11, 2021/PRNewswire/ - Emmaus Life Sciences, Inc. (OTC: EMMA) is a commercial-stage biopharmaceutical company that is also in the field of sickle cell disease treatment The leader of the company today announced a partnership with UpScript IP Holdings, a limited liability company. (UpScript), provides telemedicine solutions for patients with sickle cell disease and expands the use of Endari®, Emmaus' prescription L-glutamine oral powder for the treatment of sickle cell disease.

The telemedicine cooperation with UpScript will allow patients to seek medical treatment without leaving home, thereby eliminating the risk of infection that may occur during the visit. Other benefits for patients include being able to obtain Endari’s doctor’s authorization and prescription on the same day, and deliver the prescription directly to their home in just a few days.

"This partnership with UpScript is a proven, direct-to-consumer telemedicine platform that provides us with another key way through which we can meaningfully improve sickle cell patients’ access to Endari. "Doctor of Medicine, Master of Public Health, Chairman and CEO Yutaka Niihara said Emmaus. "Endari aims to reduce the acute complications of sickle cell disease in adults and pediatric patients aged 5 years and older, and is recognized as an important tool for the treatment of this debilitating disease. It is convenient and does not require preliminary or follow-up blood test monitoring. Endari has It is well tolerated and can be easily consumed with water, juice or other liquids. We are proud to work with UpScript and believe that Endari may become the first choice for the treatment of sickle cell disease patients in a telemedicine environment."

George Sekulich, Senior Vice President of Global Commercialization at Emmaus, added: "Once deployed, our telemedicine service will provide patients with a new and convenient way to receive Endari and improve their overall experience. We plan to do so in the coming months. Launch this key service within."

Peter Ax, CEO and founder of UpScript, said: “UpScript looks forward to launching this partnership and improving Endari’s access to sickle cell disease patients. “Our direct-to-consumer platform enables pharmaceutical companies to facilitate, Reach patients in a safe and effective way, and improve the lives of patients by making medicines more accessible and affordable. "

About Emmaus Life Sciences Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and a leader in the treatment of sickle cell disease. The company currently sells Endari® (L-glutamine oral powder) approved by the U.S. Food and Drug Administration to reduce acute complications of sickle cell disease in adults and children 5 years and older. The company is also committed to discovering and developing innovative therapies and therapies for certain rare and orphan diseases and diseases that affect larger populations (such as diverticulosis). For more information, please visit www.emmausmedical.com.

About UpScript UpScript provides pharmaceutical companies and consumer product companies with a direct-to-consumer telemedicine platform that can easily obtain high-quality healthcare services. In 2002, we became the first company in the United States to obtain permission to prescribe on the Internet through online physician consultation. Since then, we have served more than one million consumers in all fifty states. Learn more on www.UpScriptHealth.com.

About Endari® (prescription grade L-glutamine oral powder) Endari® is Emmaus' prescription grade L-glutamine oral powder, which was approved by the FDA in July 2017 for the treatment of sickle in adults and children aged 5 years and older Shape cell disease. Endari® began to be sold in the United States in 2018.

Indications Endari® is used to reduce acute complications of sickle cell disease in adults and children aged 5 years and older.

Important safety information The most common adverse reactions in clinical studies (incidence> 10%) are constipation, nausea, headache, abdominal pain, cough, limb pain, back pain, and chest pain.

Adverse reactions leading to treatment interruption included 1 case each of hypersplenism, abdominal pain, indigestion, burning sensation and hot flashes.

The safety and effectiveness of Endari in pediatric patients with sickle cell disease under 5 years of age have not been established.

For more information, see Endari's full prescribing information: www.ENDARIrx.com/PI.

About sickle cell disease There are approximately 100,000 people with sickle cell disease (SCD) in the United States and millions of people worldwide. The sickle gene exists in every ethnic group, not just among people of African descent. In the United States, it is estimated that one in 365 African Americans and 16,300 Hispanic Americans was born with SCD. 1 The genetic mutation that causes SCD causes an individual's red blood cells to deform into a "C" or sickle shape, reducing their ability to transport oxygen throughout the body. These sickle red blood cells decompose rapidly, become very viscous, and have a tendency to clump together, causing them to get stuck in blood vessels and cause damage. The result is reduced blood flow to remote organs, which can lead to physical symptoms such as pain, tissue and organ damage, and premature death. 2

1 Source: data and statistics on sickle cell disease-National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, December 2020. 2 Source: Committee on Addressing Sickle Cell Disease-Strategic Plan and Blueprint for Action-National Academy of Sciences Press, 2020.

Forward-Looking Statements This press release contains forward-looking statements made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 (as amended), including statements regarding the possible increase in access to Endari through telemedicine. These forward-looking statements are subject to many time-varying assumptions, risks and uncertainties, including risks inherent in the regulatory approval process and other previously disclosed in the company’s annual report on Form 10-K/A to the US Securities and Exchange Commission. The actual results of the SEC's report issued on August 10, 2021 and our quarterly report on Form 10-Q may differ materially. Such forward-looking statements are only effective on the date they are made, and Emmaus assumes no obligation to update them, unless required by law.

View original content and download multimedia: https://www.prnewswire.com/news-releases/emmaus-life-sciences-announces-partnership-with-upscript-to-provide-telehealth-solutions-to-sickle-cell-disease- Patient-301422030.html

Source: Emmaus Life Sciences, Inc.

Tonix Pharmaceuticals (NASDAQ: TNXP) stock is a much-discussed title among the crowd of memetic stocks, and the latest situation emerged in a series of up and down trading days on Monday. With the support of encouraging patent news, the biotech company's stock price rose nearly 7%. Tonix announced that last Tuesday, it obtained a patent for "Clover family factor protein and its use."

The dramatic increase in Medicare Part B premiums in 2022 reflects the skyrocketing price of a controversial Alzheimer's disease drug. The increase in premiums will not only weaken the newly added social security living allowance, as a result... Continue reading → Why did the post about the soaring premium of Medicare Part B in 2022 first appear on the SmartAsset blog.

U.S. marijuana stocks rose on Monday, after a draft legislation led by the Republican Party is expected to be announced in the United States to legalize marijuana in the United States

Perhaps you understand intuitively that because the liver filters the toxins in your body, it is essential to maintain the health of this vital organ. Usually, when we talk about liver damage, the first thing that comes to mind is alcohol. However, new research shows that a completely different beverage usually damages the liver... Unlike alcohol, this beverage does not have a minimum age requirement. Read on to learn what Boston's medical and public health researchers might be saying

Coronavirus did not take a day off: The virus continued to spread, and Dr. Sanjay Gupta of CNN revealed five places where the spread of the coronavirus is more likely than other places. Dr. Gupta said: "The main place where the virus spreads in our society is exactly these five main locations." Continue reading to hear his warning-and to ensure the health of you and others, don’t miss these cases where you have been infected with COVID. For sure signs. 1 The Supreme Court of Chapel prevents the state COVID-19 from taking a break

With age, many things will change. For some elderly people, these changes may include their bathroom habits. A report issued by the Centers for Disease Control and Prevention (CDC) in 2014 showed that 51% of adults over the age of 65 suffer from bladder or bowel incontinence-these two conditions usually cause frequent, sudden or uncontrollable Impulse to go out. “We found that half of the population had experienced urine leakage or accidental intestinal leakage, and about 25% had moderate, severe or severe

ANTIVAX history-the world's first anti-vaccination campaign spread the fear of half-bovine babies. 1,240 words, by Jess McHugh (special issue). Two photos. In the early 19th century, the British people finally received the first vaccine in history, which promised to protect them from smallpox, one of the deadliest diseases of the time. However, many Britons are skeptical of vaccines, and their concerns go far beyond the fatigue and arm soreness caused by many modern injections. side effect

The threat of a surge in the northern hemisphere in winter is imminent, just as the so-called delta wave is beginning to fade in the United States, this time, it may promote the resolution of the outstanding issues surrounding the launch of the US booster. This fall, US regulators did not allow all adults to receive the third dose of the Covid-19 vaccine, which hindered the launch of the Biden government's August pledge. Now, as the number of cases rises again, it seems that the government will once again promote a general increase for all adults in the United States

On Thanksgiving and Christmas last year, people all over the United States decided not to visit their relatives, while the coronavirus was spreading everywhere. However, as our second holiday in the COVID pandemic approaches, the situation is very different. Millions of people are now vaccinated, and the idea of ​​traveling and gathering with others this year is much safer than in 2020. Several health officials have agreed, including the Centers for Disease Control and Prevention (CDC) D

The company stated that Sandrock will retire at the end of this year, and Priya Singhal will temporarily lead the R&D department until a permanent successor is determined. Sandrock has been the face of Biogen's controversial drug Aduhelm, which was approved by the U.S. Food and Drug Administration in June because it can remove the viscous deposits of another protein called amyloid beta Substance-a protein that may cause Alzheimer's disease.

Bianca Hayes succeeded in losing weight through gastric tube bypass, but after giving birth to her daughter, she recovered and hoped to make another change on my 600 pounds. Life

There are currently 50 million people living with dementia worldwide, and this number is expected to triple by 2050. The dramatic increase in the prevalence of this disease has been called a "global emergency" and has triggered new research possibilities on how we can reduce the risk of dementia in the following situations. This also encourages experts to disseminate information about risk factors that may increase your chances of diagnosis. In fact, researchers at the Johns Hopkins School of Medicine stated that there is a little-known risk factor with five times the i

Moderna Inc. said on Friday that Health Canada has authorized a booster dose of its COVID-19 vaccine for people who are at least 18 years old, that is, at least six months after the completion of the main two-dose regimen. Last month, U.S. regulators signed an agreement to extend the booster to Americans vaccinated with Moderna or Johnson & Johnson, and said that eligible people can get a brand different from the vaccine they initially received. Moderna's stock fell 1.1% in early trading. Previously, the

After scientists have conducted successful experiments on animals, a vaccine against Alzheimer's disease may be about to come out.

A professional mixed martial arts player was impounded for $1 million on suspicion of being stabbed in Guam.

Do you mean tight hips? join the club.

Doctors in India’s most populous state are scrambling to control the outbreak of a mosquito-borne disease related to birth defects. In the past three weeks, more than 120 people in Kanpur, Uttar Pradesh have tested positive for Zika virus-the first time the state has been detected The virus. However, the actual number of infections may be much higher because in most cases, the virus causes only mild fever and is often mistaken for flu. But 10% in California

Leapfrog Hospital Safety Grades are issued twice a year to more than 3,000 hospitals across the country, and are evaluated based on more than 30 publicly available hospital safety data such as hygiene, falls, doctor communication and discharge information.

When it comes to everyday behaviors that lead to aging, excessive drinking and smoking are well-known illegal behaviors at this point-you don't need to be told that they are harmful to your health and appearance. But do you know that there are other less obvious factors that may cause us to age prematurely? You may be surprised that the most seemingly harmless habits can actually cause significant damage to your DNA and disrupt your otherwise healthy lifestyle. read

According to data from the National Oceanic and Atmospheric Administration (NOAA), fish is one of the most popular sources of protein in the United States, and the average U.S. resident consumes about 16.1 pounds of fish per person per year. Gives multiple health benefits, but not every type of fish is the same in terms of your health. In fact, seven types of fish have been withdrawn from the market due to serious health risks